MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $21 | $16 | $18 |
| - Cash | $3 | $1 | $1 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $20 | $15 | $15 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$23 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.18 | -0.091 | -0.11 | -0.16 |
| % Growth | -1,203.9% | 17.7% | 31.3% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$2 | -$2 |